Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress‐inducing agents

Tatiana I. Ignashkova(BioMed X Institute), Mathieu Gendarme(BioMed X Institute), Katrin Peschk(Merck KGaA, Darmstadt (Germany)), Hans‐Michael Eggenweiler(Merck KGaA, Darmstadt (Germany)), Ralph K. Lindemann(Merck KGaA, Darmstadt (Germany)), Jan H. Reiling(BioMed X Institute)
Traffic
May 9, 2017
Cited by 36Open Access
Full Text

Abstract

The Golgi apparatus is part of the secretory pathway and of central importance for modification, transport and sorting of proteins and lipids. ADP-ribosylation factors, whose activation can be blocked by brefeldin A (BFA), play a major role in functioning of the Golgi network and regulation of membrane traffic and are also involved in proliferation and migration of cancer cells. Due to high cytotoxicity and poor bioavailability, BFA has not passed the preclinical stage of drug development. Recently, AMF-26 and golgicide A have been described as novel inhibitors of the Golgi system with antitumor or bactericidal properties. We provide here further evidence that AMF-26 closely mirrors the mode of action of BFA but is less potent. Using several human cancer cell lines, we studied the effects of AMF-26, BFA and golgicide A on cell homeostasis including Golgi structure, endoplasmic reticulum (ER) stress markers, secretion and viability, and found overall a significant correlation between these parameters. Furthermore, modulation of ADP-ribosylation factor expression has a profound impact on Golgi organization and survival in response to Golgi stress inducers.


Related Papers

No related papers found

Powered by citation graph analysis